Enhancing Protein NMR for Drug Discovery – The Role of Deuteration

Structural Biology in Drug Discovery

In drug discovery, understanding the structure and dynamics of target proteins is essential for rational design and optimisation of therapeutic compounds. Structural biology provides the tools to achieve this, offering atomic-level insights into biomolecular interactions. Currently, X-ray crystallography, cryo-electron microscopy (cryo-EM), and nuclear magnetic resonance (NMR) are the only techniques capable of achieving such resolution. It is important to emphasise that none of these methods is inherently superior; rather, they are complementary, as we have discussed in this blog.
However, sample preparation is critical for all structural biology techniques. In this article, we focus on the importance of protein deuteration in enhancing data quality for NMR studies.

NMRs Role in Drug Discovery

Among these techniques, NMR offers unique advantages for drug discovery – particularly in studying proteins in solution, fragment-based screening, and characterising dynamic interactions. The quality of NMR data, however, is highly dependent on sample preparation. In this blog, we highlight the importance of protein deuteration in improving NMR data quality, especially for large protein targets.

Isotopic Labelling

NMR is a powerful and flexible technique that enables the study of biomolecules in solution, including small molecules, peptides, proteins, nucleic acids, carbohydrates, and lipids. Its ability to probe molecular dynamics and binding events in near-physiological conditions makes it especially valuable in early-stage drug discovery. While there is no strict size limit for NMR, larger proteins often present challenges due to signal overlap and reduced signal-to-noise (S/N) ratios.
To overcome these limitations, isotopic labelling with ¹⁵N and/or ¹³C and partial deuteration is commonly used. These isotopes must be incorporated through de novo synthesis, either in prokaryotic or eukaryotic expression systems. Once labelled, proteins can be analysed using 2D-NMR, where a single well-resolved signal is observed per every ¹H/¹⁵N and/or ¹H/¹³C correlation.

How Deuteration Improves NMR Data

For proteins larger than ~25 kDa—common among drug targets—NMR spectra often suffer from broadened signals and poor S/N due to increased relaxation rates caused by ¹H–¹H dipolar coupling. One effective strategy to address this is deuteration: replacing non-exchangeable protons with deuterons (²H) in CH, CH₂, and CH₃ groups.
This is achieved by expressing the protein in partially or fully deuterated media — a service we offer as part of our protein expression platform. Deuteration reduces dipolar interactions, increases relaxation times, and significantly enhances the S/N ratio of ¹H/¹⁵N resonances. As a result, researchers can obtain more complete and higher-quality datasets—not only for hydrogen and nitrogen atoms, but also for ¹H/¹³C resonances when ¹³C labelling is included.

CASE STUDY: Improving NMR with 80% Deuteration

As an example, we present a case study from one of our internal development projects. We successfully replaced approximately 80% of the aliphatic protons with deuterons, as shown in the ¹H NMR spectrum (Figure. 1, region -0.5 to 4.5 ppm).

This 80% deuteration had a substantial impact on the quality of the 2D ¹H/¹⁵N NMR spectra. As shown in Figure 2, several HN resonances exhibited marked improvements in S/N ratio, enabling more confident peak assignment and structural interpretation.

Summary

Deuteration is a powerful strategy to enhance NMR data quality, particularly for larger proteins that are often key targets in drug discovery. By improving signal resolution and completeness of datasets, deuteration enables more accurate structural insights, better fragment screening, and more informed decision-making in early-stage drug development.